CRISPR - From Trial to Pharmacy Shelf: Scaling the First ...

What this episode covers

Ryan Cole examines Casgevy, the world's first approved CRISPR medicine for sickle cell disease and beta thalassemia. While revolutionary, delivering this autologous gene therapy faces massive challenges: a $2.2 million price tag, months-long manufacturing, only 50 global treatment centers, and access barriers in regions with highest disease burden. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Share this episode

Similar Episodes

Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61

Jul 6, 2026 ·74m

The Globalist Plan: Allan Paul Roberts On Society, Power, & The Future

Jul 4, 2026 ·46m

The Rise of Pediatric Diabetes: What Parents Need To Know About Children's Metabolic Health

Jul 3, 2026 ·44m

#401 The First Precision Medicine for Achondroplasia with Dr. Ravi Savarirayan

Jul 3, 2026 ·36m

Listen to: What Could Go Right?

Jun 29, 2026 ·11m

Can The Brain Heal Itself New Approaches To Parkinson's & Neurodegenerative Disease

Jun 26, 2026 ·28m

Similar Podcasts

Finding Genius Podcast Richard Jacobs Podcast interviews with genius-level (top .1%) practitioners, scientists, researchers, clinicians and professionals in Cancer, 3D Bio Printing, CRISPR-CAS9, Ketogenic Diets, the Microbiome, Extracellular Vesicles, and more.Subscribe today for the latest medical, health and bioscience insights from geniuses in their field(s). DNA Today: A Genetics Podcast Kira Dineen, Gene Pool Media Discover New Advances in the world of genetics, from technology like CRISPR to rare diseases to new research. For over a decade, multi-award winning podcast ”DNA Today” has brought you the voices of leaders in genetics. Host Kira Dineen brings her genetics expertise to interview geneticists, genetic counselors, patient advocates, biotech leaders, researchers, and more.***Best 2020, 2021, and 2022 Science and Medicine Podcast Award Winner***Learn more (and stream all 380+ episodes) at DNAtoday.com. You can contact the show at [email protected] show is part of "Gene Pool Media: The Science Podcast Network" head to GenePoolMedia.com to explore all our science themed shows. Designer Genes: A Conversation about CRISPR Efrain C., Hope J., Maria R., Sanjay A.L. From Mendel to modern laboratories, genome-editing has fascinated the minds of many. Recently, the CRISPR-Cas9 system has been a major advancement in genome editing. Though this newly discovered mechanism has shown the potential to cure life-threatening genetic problems, the novelty of it has caused some concerns over potential ethical violations. Designer Genes is a conversation hosted by four curious biology undergraduates at Emory University that attempts to bridge the gap between scientific knowledge of CRISPR and the general public’s understanding. See website for references. Flot.bio x Philip Hemme Flot.bio Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free.Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, Edwin Moses, Bahija Jallal @Immunocore, and more. Your host Philip animates the conversation to dig out exciting, and sometimes contrarian, ideas.

Frequently Asked Questions

How long is this episode of CRISPR?

This episode is 26 minutes long.

When was this CRISPR episode published?

This episode was published on April 10, 2026.

What is this episode about?

Ryan Cole examines Casgevy, the world's first approved CRISPR medicine for sickle cell disease and beta thalassemia. While revolutionary, delivering this autologous gene therapy faces massive challenges: a $2.2 million price tag, months-long...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this CRISPR episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.